Covishield manufacturing capability 250-275 million doses a month



The present vaccine manufacturing capability of Covishield produced by Serum Institute of India is round 250-275 million doses monthly whereas it’s about 50-60 million doses monthly for Covexin of Bharat Biotech, the Rajya Sabha was knowledgeable on Tuesday. .



More News click here